Search research articles
Contact Us
Filters
Showing results (721-730 of 918) with videos related to
Page
of 92
Sort By:
Molecular Cancer Therapeutics
|
September 30, 2017
CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Chang-Xin Shi, K Martin Kortüm, Yuan Xiao Zhu, et al.
The American Review of Respiratory Disease
|
April 1, 1990
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist
R D Krell, D Aharony, C K Buckner, et al.
Journal of Virology
|
February 20, 2024
Collateral sensitivity increases the efficacy of a rationally designed bacteriophage combination to control <i>Salmonella enterica</i>
Luke Acton, Hannah V Pye, Gaëtan Thilliez, et al.
Scientific Data
|
March 7, 2025
Fire ecology database for documenting plant responses to fire events in Australia
José Rafael Ferrer-Paris, Ada Sánchez-Mercado, William K Cornwell, et al.
Nucleic Acids Research
|
October 29, 2020
DescribePROT: database of amino acid-level protein structure and function predictions
Bi Zhao, Akila Katuwawala, Christopher J Oldfield, et al.
Blood
|
December 29, 2016
Multiple myeloma cells' capacity to decompose H<sub>2</sub>O<sub>2</sub> determines lenalidomide sensitivity
Sinto Sebastian, Yuan X Zhu, Esteban Braggio, et al.
Genome Research
|
February 14, 2020
TraDIS-Xpress: a high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance
Muhammad Yasir, A Keith Turner, Sarah Bastkowski, et al.
The Science of the Total Environment
|
June 26, 2007
Mercury concentrations and space use of pre-breeding American avocets and black-necked stilts in San Francisco Bay
Joshua T Ackerman, Collin A Eagles-Smith, John Y Takekawa, et al.
Blood
|
November 15, 2014
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2
Yuan Xiao Zhu, Hongwei Yin, Laura A Bruins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
A Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Page
of 92
Search research articles
Search
Showing results (721-730 of 918) with videos related to
Sort By:
Page
of 92
Molecular Cancer Therapeutics
|
September 30, 2017
CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Chang-Xin Shi, K Martin Kortüm, Yuan Xiao Zhu, et al.
The American Review of Respiratory Disease
|
April 1, 1990
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist
R D Krell, D Aharony, C K Buckner, et al.
Journal of Virology
|
February 20, 2024
Collateral sensitivity increases the efficacy of a rationally designed bacteriophage combination to control <i>Salmonella enterica</i>
Luke Acton, Hannah V Pye, Gaëtan Thilliez, et al.
Scientific Data
|
March 7, 2025
Fire ecology database for documenting plant responses to fire events in Australia
José Rafael Ferrer-Paris, Ada Sánchez-Mercado, William K Cornwell, et al.
Nucleic Acids Research
|
October 29, 2020
DescribePROT: database of amino acid-level protein structure and function predictions
Bi Zhao, Akila Katuwawala, Christopher J Oldfield, et al.
Blood
|
December 29, 2016
Multiple myeloma cells' capacity to decompose H<sub>2</sub>O<sub>2</sub> determines lenalidomide sensitivity
Sinto Sebastian, Yuan X Zhu, Esteban Braggio, et al.
Genome Research
|
February 14, 2020
TraDIS-Xpress: a high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance
Muhammad Yasir, A Keith Turner, Sarah Bastkowski, et al.
The Science of the Total Environment
|
June 26, 2007
Mercury concentrations and space use of pre-breeding American avocets and black-necked stilts in San Francisco Bay
Joshua T Ackerman, Collin A Eagles-Smith, John Y Takekawa, et al.
Blood
|
November 15, 2014
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2
Yuan Xiao Zhu, Hongwei Yin, Laura A Bruins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
A Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Page
of 92